Thursday, July 18, 2013

Company announcements: Hartawan, 5WA, Lyxor Cmdty 10US$, HanKore

Hartawan - DISCLOSURE OF INTEREST/CHANGES IN INTEREST OF DIRECTOR/CHIEF EXECUTIVE OFFICER

Announcement Type: DISCLOSURE OF INTEREST/CHANGES IN INTEREST
Company: HARTAWAN HLDGS LTD
Stock Code/Name: 5FU - Hartawan

DISCLOSURE OF INTEREST/CHANGES IN INTEREST OF DIRECTOR/CHIEF EXECUTIVE OFFICER
* Asterisks denote mandatory information
Name of Announcer * HARTAWAN HLDGS LTD  
Company Registration No. 200300950D  
Announcement submitted on behalf of HARTAWAN HLDGS LTD  
Announcement is submitted with respect to * HARTAWAN HLDGS LTD  
Announcement is submitted by * Winstedt Chong  
Designation * Executive Chairman  
Date & Time of Broadcast 18-Jul-2013 18:19:37  
Announcement No. 00098  
>> ANNOUNCEMENT DETAILS
The details of the announcement start here ...
Person(s) giving notice * Director/Chief Executive Officer who may also be a substantial shareholder/unitholder (Form 1)  
Date of receipt of notice by Listed Issuer * 18-07-2013  
Attachments
Total size = 114K
(2048K size limit recommended)
Note: The PDF attachment is only supported by Adobe Reader 9.0 and above. If you are not able to view the attachment online, please right-click the attachment link and save the file onto your local machine. Please open the downloaded file using Adobe Reader 9.0 and above.



5WA - MISCELLANEOUS :: DISCLOSURE OF INTEREST / CHANGES IN INTEREST - SPONSOR'S STATEMENT

Announcement Type: MISCELLANEOUS
Company: INTL HEALTHWAY CORP LIMITED
Stock Code/Name: 5WA - 5WA

MISCELLANEOUS
* Asterisks denote mandatory information
Name of Announcer * INTL HEALTHWAY CORP LIMITED  
Company Registration No. 201304341E  
Announcement submitted on behalf of INTL HEALTHWAY CORP LIMITED  
Announcement is submitted with respect to * INTL HEALTHWAY CORP LIMITED  
Announcement is submitted by * Dr Jong Hee Sen  
Designation * Executive Chairman  
Date & Time of Broadcast 18-Jul-2013 18:36:29  
Announcement No. 00119  
>> ANNOUNCEMENT DETAILS
The details of the announcement start here ...
Announcement Title * Disclosure of Interest / Changes in Interest - Sponsor's Statement  
Description
We refer to the announcement number 113 (the "Announcement") released earlier today by the Company in relation to a director's (including a director who is a substantial shareholder) interest and change in interest. The Announcement has been prepared by the Company and its contents have been reviewed by the Company's sponsor, PrimePartners Corporate Finance Pte. Ltd. (the "Sponsor"), for compliance with the relevant rules of the Singapore Exchange Securities Trading Limited (the "SGX-ST"). The Sponsor has not independently verified the contents of the Announcement.

The Announcement has not been examined or approved by the SGX-ST and the SGX-ST assumes no responsibility for the contents of the Announcement, including the correctness of any of the statements or opinions made or reports contained in the Announcement.

The contact person for the Sponsor is Mr Mark Liew, Managing Director, Corporate Finance, at 20 Cecil Street, #21-02 Equity Plaza, Singapore 049705, telephone (65) 6229 8088.  
Attachments
Total size = 0
(2048K size limit recommended)



5WA - DISCLOSURE OF INTEREST/CHANGES IN INTEREST OF DIRECTOR/CHIEF EXECUTIVE OFFICER

Announcement Type: DISCLOSURE OF INTEREST/CHANGES IN INTEREST
Company: INTL HEALTHWAY CORP LIMITED
Stock Code/Name: 5WA - 5WA

DISCLOSURE OF INTEREST/CHANGES IN INTEREST OF DIRECTOR/CHIEF EXECUTIVE OFFICER
* Asterisks denote mandatory information
Name of Announcer * INTL HEALTHWAY CORP LIMITED  
Company Registration No. 201304341E  
Announcement submitted on behalf of INTL HEALTHWAY CORP LIMITED  
Announcement is submitted with respect to * INTL HEALTHWAY CORP LIMITED  
Announcement is submitted by * Dr Jong Hee Sen  
Designation * Executive Chairman  
Date & Time of Broadcast 18-Jul-2013 18:30:47  
Announcement No. 00113  
>> ANNOUNCEMENT DETAILS
The details of the announcement start here ...
Person(s) giving notice * Director/Chief Executive Officer who may also be a substantial shareholder/unitholder (Form 1)  
Date of receipt of notice by Listed Issuer * 17-07-2013  
Attachments
Total size = 113K
(2048K size limit recommended)
Note: The PDF attachment is only supported by Adobe Reader 9.0 and above. If you are not able to view the attachment online, please right-click the attachment link and save the file onto your local machine. Please open the downloaded file using Adobe Reader 9.0 and above.



Lyxor Cmdty 10US$ - MISCELLANEOUS :: CREDIT RATING OF SOCIETE GENERALE

Announcement Type: MISCELLANEOUS
Company: LYXOR COMMODITIES CRB FUND 10
Stock Code/Name: A0W - Lyxor Cmdty 10US$

MISCELLANEOUS
* Asterisks denote mandatory information
Name of Announcer * SG SECURITIES (HK) LIMITED  
Company Registration No. 136771  
Announcement submitted on behalf of LYXOR COMMODITIES CRB FUND 10  
Announcement is submitted with respect to * LYXOR COMMODITIES CRB FUND 10  
Announcement is submitted by * Lyxor Group  
Designation * Lyxor Group  
Date & Time of Broadcast 18-Jul-2013 18:19:49  
Announcement No. 00099  
>> ANNOUNCEMENT DETAILS
The details of the announcement start here ...
Announcement Title * Credit Rating of Societe Generale  
Description
   
Attachments
Total size = 41K
(2048K size limit recommended)



HanKore - MISCELLANEOUS :: PRESS RELEASE

Announcement Type: MISCELLANEOUS
Company: HANKORE ENVIRONMENT TEC GRPLTD
Stock Code/Name: B22 - HanKore

MISCELLANEOUS
* Asterisks denote mandatory information
Name of Announcer * HANKORE ENVIRONMENT TEC GRPLTD  
Company Registration No. 34074  
Announcement submitted on behalf of HANKORE ENVIRONMENT TEC GRPLTD  
Announcement is submitted with respect to * HANKORE ENVIRONMENT TEC GRPLTD  
Announcement is submitted by * CHEN DAWEI  
Designation * EXECUTIVE CHAIRMAN  
Date & Time of Broadcast 18-Jul-2013 18:22:06  
Announcement No. 00102  
>> ANNOUNCEMENT DETAILS
The details of the announcement start here ...
Announcement Title * PRESS RELEASE  
Description
Please see attachment.  
Attachments
Total size = 87K
(2048K size limit recommended)



No comments:

Post a Comment